Search

Your search keyword '"Platelet Biology & its Disorders"' showing total 36 results

Search Constraints

Start Over You searched for: Descriptor "Platelet Biology & its Disorders" Remove constraint Descriptor: "Platelet Biology & its Disorders"
36 results on '"Platelet Biology & its Disorders"'

Search Results

1. Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets

2. Glycoprotein Ib clustering in platelets can be inhibited by α-linolenic acid as revealed by cryo-electron tomography

3. Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets

4. Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice

5. Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A

6. High-throughput elucidation of thrombus formation reveals sources of platelet function variability

7. Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects

8. All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement–interleukin-1β loop

9. Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release

10. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

11. Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions

12. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders : the SPATA-DVT study

13. Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy

14. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis

15. Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis

16. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

17. The secret afterlife of platelets

18. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

19. The child with immune thrombocytopenia: to treat or not to treat, is that still the question?

20. CD45 expression discriminates waves of embryonic megakaryocytes in the mouse

21. Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation

22. Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia

23. Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence

24. The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation

25. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial

26. Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice

27. Anti-apoptotic

28. Molecular mechanisms of bleeding disorderassociated GFI1B

29. Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI

30. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies

31. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia

32. Platelet Munc13-4 regulates hemostasis, thrombosis and airway inflammation

33. Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012

34. Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features

35. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

36. Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Catalog

Books, media, physical & digital resources